Intravenous immunoglobulin: prospects in patients with autoimmune rheumatic diseases

Intravenous immunoglobulin: prospects in patients with autoimmune rheumatic diseases

The published data on efficiency of intravenous immunoglobulin (IVIG) in patients with autoimmune rheumatic diseases (RD) are analyzed. IVIG is the drug of choice in patients with Kawasaki disease, idiopathic thrombocytopenic purpura, dermatomyositis, etc. It is reasonable to use IVIG in RD patients...

Full description

Saved in:

Bibliographic Details
Main Authors:	Elena Aleksandrovna Aseeva, S K Solov’ev
Format:	Article
Language:	Russian
Published:	IMA-PRESS LLC 2014-03-01
Series:	Современная ревматология
Subjects:	intravenous immunoglobulin kawasaki disease dermatomyositis idiopathic thrombocytopenic purpura vasculitis aumoimmune rheumatic diseases
Online Access:	https://mrj.ima-press.net/mrj/article/view/510
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The place of intravenous immunoglobulin in rheumatic diseases
by: N. V. Seredavkina, et al.
Published: (2016-01-01)

INTRAVENOUS IMMUNOGLOBULIN IN PEDIATRIC RHEUMATOLOGY PRACTICE
by: E. I. Alexeeva, et al.
Published: (2015-04-01)

Peculiar features of intravenous immunoglobulins application in rheumatic diseases
by: O. N. Egorova, et al.
Published: (2024-06-01)

Effect of additional intravenous immunoglobulin for infliximab-refractory Kawasaki disease: a cohort study
by: Satoki Hatano, et al.
Published: (2025-05-01)

Establishment and validation of risk prediction model to predict intravenous immunoglobulin-resistance in Kawasaki disease based on meta-analysis of 15 cohorts
by: Shuhui Wang, et al.
Published: (2025-02-01)

CAUSES OF DEVELOPMENT OF ACUTE AND CHRONIC THROMBOCYTOPENIA IN CHILDREN OF IRKUTSK REGION
by: N. N. Martynovich, et al.
Published: (2018-09-01)

Impact of intravenous immunoglobulin treatment on peripheral blood cells in children with Kawasaki disease complicated with coronary artery lesion
by: Junshan Zhao, et al.
Published: (2025-02-01)

Interpretable web-based machine learning model for predicting intravenous immunoglobulin resistance in Kawasaki disease
by: Ying He, et al.
Published: (2025-06-01)

INTRAVENOUS IMMUNOGLOBULIN APPLICATION IN CLINICAL PRACTICE
by: T. V. Latysheva, et al.
Published: (2013-01-01)

The effects of glucocorticoid plus intravenous immunoglobulin (IVIG) vs IVIG alone on platelet activation in children with Kawasaki disease
by: Qiong-Qiong Wang, et al.
Published: (2023-08-01)

EXPERIENCE OF INTRAVENOUS INJECTION OF NORMAL HUMAN IMMUNOGLOBULIN IN A PATIENT WITH KAWASAKI SYNDROME
by: T. V. Sleptsova, et al.
Published: (2014-07-01)

IVIG Resistance in Kawasaki Disease: Clinical and Laboratory Risk Factors and the Potential Role of Administration Timing
by: Peng Y, et al.
Published: (2025-05-01)

The efficacy and safety of intravenous immunoglobulin infusion in 12 h for the initial treatment of Kawasaki disease
by: Satoshi Asano, et al.
Published: (2024-09-01)

A visualized nomogram to predict intravenous immunoglobulin resistance in Kawasaki disease: a study based on the population in Southern China
by: Xinping Lin, et al.
Published: (2025-04-01)

Kawasaki disease with cardiac involvement revealed by acute pancreatitis in an adult: a rare case report
by: Leila BARAKAT, et al.
Published: (2025-05-01)

High Efficiency of Human Normal Immunoglobulin for Intravenous Administration in a Patient with Kawasaki Syndrome Diagnosed in the Later Stages
by: Tatyana V. Sleptsova, et al.
Published: (2016-09-01)

Immune thrombocytopenia: literature review
by: S. G. Zakharov
Published: (2024-09-01)

Corrigendum: The incidence of periungual desquamation and thrombocytosis in Kawasaki disease and the importance of systematic observation in the subacute phase
by: Beom Joon Kim, et al.
Published: (2025-03-01)

Clinical and Laboratory Characteristics of Children with Chronic Idiopathic Thrombocytopenic Purpura
by: Milica Cekerevac, et al.
Published: (2025-05-01)

Child with fever and a rash
by: Faith Spratt, et al.
Published: (2023-04-01)

Exploring the predictive factors in the gastrointestinal involvement of patients with immunoglobulin A vasculitis
by: Betül Öksel, et al.
Published: (2024-11-01)

Association between C-reactive protein–albumin–lymphocyte (CALLY) index with intravenous immunoglobulin non-response in Kawasaki disease
by: Yan Duan, et al.
Published: (2025-12-01)

Impact of 10% vs. 5% immunoglobulin products on treatment outcomes in Kawasaki disease: a multicenter retrospective study
by: Daichi Sajiki, et al.
Published: (2025-05-01)

Kawasaki disease: do the manifestations in children observed in the Russian Federation and in foreign countries coincide?
by: N. Yu. Golovanova, et al.
Published: (2025-06-01)

Does the Use of Intravenous Immunoglobulin Improve Clinical Outcomes in Adults With Autoimmune Encephalitis? A Systematic Review
by: Anahat Kalra, et al.
Published: (2025-05-01)

The Prognostic Value of Platelet Kinetics Assessment in Pediatric Chronic Idiopathic Thrombocytopenic Purpura
by: Nebojsa Igrutinovic, et al.
Published: (2025-07-01)

Pharmacoeconomic Analysis of the Use of Thrombopoietin Receptors Agonists in Idiopathic Thrombocytopenic Purpura Therapy
by: VA Shuvaev, et al.
Published: (2017-10-01)

Idiopathic Thrombocytopenic Purpura as Initial Manifestation of Systemic Lupus Erythematosus: A Case Report
by: Fatih Bağcıer, et al.
Published: (2016-08-01)

Hodgkin Lymphoma Development After the Diagnosis of Idiopathic
by: Oktay Bilgir, et al.
Published: (2014-08-01)

Unraveling the gut: the pivotal role of intestinal mechanisms in Kawasaki disease pathogenesis
by: Enfu Tao, et al.
Published: (2024-11-01)

Role of Pyroptosis in IVIG-Resistant Kawasaki Disease and the Establishment of a New Predictive Model
by: Li S, et al.
Published: (2024-12-01)

KILLER IMMUNOGLOBULINE LIKE RECEPTOR GENE ANALYSIS IN CHRONIC LYMPHOCYTIC LEUKEMIA AND ITS RELATION WITH AUTOIMMUNITY
by: Mustafa Murat Özbalak, et al.
Published: (2021-04-01)

Protective effect of breastfeeding on Kawasaki disease: A systemic review and meta-analysis
by: Wan-Jung Yang, et al.
Published: (2024-09-01)

Secondary immune thrombocytopenic purpura: An unusual complication of scrub typhus
by: Jency Auxilia, et al.
Published: (2025-01-01)

Plasma exchange alone versus combination with intravenous immunoglobulin/methylprednisolone pulse therapy in severe systemic rheumatic diseases: a retrospective study
by: Jing Guo, et al.
Published: (2024-12-01)

Management of patients with immune thrombocytopenia in the Moscow region
by: S. G. Zakharov, et al.
Published: (2022-11-01)

Retrospective Cohort Study of Clinical Profile and IVIg Resistance in Children with Incomplete Kawasaki Disease in a Tertiary Care Center
by: Bhaskar Shenoy, et al.
Published: (2022-08-01)

Idiopathic thrombocytopenic purpura. Clinical case
by: V. V. Syvolap, et al.
Published: (2015-10-01)

SARS-COV-2 infection in a patient with Evans syndrome: A silent enemy or an ally?
by: Pantić Nikola, et al.
Published: (2020-01-01)

The role of thrombopoietin receptor agonists in the management of adult primary immune thrombocytopenia: A single centre experience
by: Virijević Marijana, et al.
Published: (2022-01-01)